PL2321273T3 - Podawanie 25-hydroksy-witaminy D3 raz w tygodniu w celu utrzymania podwyższonego stężenia we krwi w stanie równowagi farmakokinetycznej - Google Patents

Podawanie 25-hydroksy-witaminy D3 raz w tygodniu w celu utrzymania podwyższonego stężenia we krwi w stanie równowagi farmakokinetycznej

Info

Publication number
PL2321273T3
PL2321273T3 PL09801055T PL09801055T PL2321273T3 PL 2321273 T3 PL2321273 T3 PL 2321273T3 PL 09801055 T PL09801055 T PL 09801055T PL 09801055 T PL09801055 T PL 09801055T PL 2321273 T3 PL2321273 T3 PL 2321273T3
Authority
PL
Poland
Prior art keywords
once
blood concentration
hydroxy vitamin
week administration
state pharmacokinetic
Prior art date
Application number
PL09801055T
Other languages
English (en)
Inventor
Hector F Deluca
Lori A Plum
Margaret Clagett-Dame
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of PL2321273T3 publication Critical patent/PL2321273T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL09801055T 2008-07-24 2009-07-24 Podawanie 25-hydroksy-witaminy D3 raz w tygodniu w celu utrzymania podwyższonego stężenia we krwi w stanie równowagi farmakokinetycznej PL2321273T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8322308P 2008-07-24 2008-07-24
PCT/US2009/051664 WO2010011906A1 (en) 2008-07-24 2009-07-24 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
EP09801055.6A EP2321273B1 (en) 2008-07-24 2009-07-24 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration

Publications (1)

Publication Number Publication Date
PL2321273T3 true PL2321273T3 (pl) 2015-05-29

Family

ID=41570618

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09801055T PL2321273T3 (pl) 2008-07-24 2009-07-24 Podawanie 25-hydroksy-witaminy D3 raz w tygodniu w celu utrzymania podwyższonego stężenia we krwi w stanie równowagi farmakokinetycznej

Country Status (13)

Country Link
US (4) US8759328B2 (pl)
EP (1) EP2321273B1 (pl)
JP (2) JP6095891B2 (pl)
AU (1) AU2009273889B2 (pl)
CA (1) CA2731382C (pl)
DK (1) DK2321273T3 (pl)
ES (1) ES2525180T3 (pl)
HR (1) HRP20150093T1 (pl)
PL (1) PL2321273T3 (pl)
PT (1) PT2321273E (pl)
SI (1) SI2321273T1 (pl)
SM (1) SMT201500020B (pl)
WO (1) WO2010011906A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT1993559T (lt) 2006-02-03 2016-11-10 Opko Renal, Llc Vitamino d nepakankamumo ir deficito gydymas su 25-hidroksivitaminu d2 ir 25-hidroksivitaminu d3
PL2037936T3 (pl) 2006-06-21 2015-04-30 Opko Renal Llc Sposób leczenia i zapobiegania wtórnej nadczynności przytarczyc
JP5501956B2 (ja) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
CA2684778C (en) 2007-04-25 2017-09-05 Cytochroma Inc. Methods and compounds for vitamin d therapy
CN106853250A (zh) 2008-04-02 2017-06-16 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
CA2731382C (en) * 2008-07-24 2020-04-28 Wisconsin Alumni Research Foundation Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
CN105796530A (zh) * 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US10055727B2 (en) 2012-11-05 2018-08-21 Mfoundry, Inc. Cloud-based systems and methods for providing consumer financial data
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US20140296190A1 (en) * 2013-03-27 2014-10-02 Dsm Ip Assets B.V. Marketing the use of 25-hydroxyvitamin d3 to enhance cognition
WO2015102996A1 (en) * 2013-12-31 2015-07-09 Grasso Frank J Extremely high loading dose
CN114681468A (zh) 2014-08-07 2022-07-01 欧普科爱尔兰环球控股有限公司 利用25-羟基维生素d的辅助疗法
EP3053598A1 (en) * 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules
WO2017126512A1 (ja) * 2016-01-20 2017-07-27 国立大学法人島根大学 医療従事者用ヘッドライト
CR20180510A (es) 2016-03-28 2019-05-15 Opko Ireland Global Holdings Ltd Método de tratamiento con vitamina d
CN108383767B (zh) * 2018-02-06 2020-03-24 山东海能生物工程有限公司 25-羟基胆钙化醇一水合物晶体及其制备方法以及使用其的微乳液
WO2022006446A1 (en) * 2020-07-02 2022-01-06 The Uab Research Foundation Compositions and methods of treating conditions
WO2022224001A1 (en) * 2021-04-22 2022-10-27 Faes Farma, S.A. Universal dosage regime of 25-hydroxy vitamin d3

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607888A (en) * 1969-08-07 1971-09-21 Wisconsin Alumni Res Found 25-hydroxytachysterol3 25-hydroxydihydrotachysterol3 and methods for preparing same
ES2139674T3 (es) * 1992-09-15 2000-02-16 Thys Jacobs Susan Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio.
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
JP2005531532A (ja) * 2002-04-05 2005-10-20 メルク　エンド　カムパニー　インコーポレーテッド アレンドロナートおよびビタミンｄ製剤を用いる骨吸収阻害法
US20050101576A1 (en) * 2003-11-06 2005-05-12 Novacea, Inc. Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
KR20060015316A (ko) * 2003-05-28 2006-02-16 넥타르 테라퓨틱스 아미노산 및/또는 인지질로 부분 또는 완전 코팅된수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의분무 건조법
LT1993559T (lt) * 2006-02-03 2016-11-10 Opko Renal, Llc Vitamino d nepakankamumo ir deficito gydymas su 25-hidroksivitaminu d2 ir 25-hidroksivitaminu d3
PL2037936T3 (pl) * 2006-06-21 2015-04-30 Opko Renal Llc Sposób leczenia i zapobiegania wtórnej nadczynności przytarczyc
JP5501956B2 (ja) * 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
CA2684778C (en) * 2007-04-25 2017-09-05 Cytochroma Inc. Methods and compounds for vitamin d therapy
KR101495578B1 (ko) * 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
ES2599761T3 (es) * 2008-02-13 2017-02-03 Dsm Ip Assets B.V. Uso de 25-hidroxi-vitamina D3 y vitamina D para afectar a la fisiología muscular humana
CA2731382C (en) * 2008-07-24 2020-04-28 Wisconsin Alumni Research Foundation Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
CN105796530A (zh) * 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物

Also Published As

Publication number Publication date
EP2321273A4 (en) 2011-11-30
SI2321273T1 (sl) 2015-03-31
SMT201500020B (it) 2015-03-05
DK2321273T3 (en) 2015-02-16
JP2011529081A (ja) 2011-12-01
US20140100203A1 (en) 2014-04-10
ES2525180T3 (es) 2014-12-18
US20150374722A1 (en) 2015-12-31
CA2731382C (en) 2020-04-28
CA2731382A1 (en) 2010-01-28
US20110105444A1 (en) 2011-05-05
JP2017061545A (ja) 2017-03-30
EP2321273A1 (en) 2011-05-18
HRP20150093T1 (hr) 2015-03-27
AU2009273889A1 (en) 2010-01-28
US20200281947A1 (en) 2020-09-10
US8759328B2 (en) 2014-06-24
PT2321273E (pt) 2014-12-29
EP2321273B1 (en) 2014-11-19
WO2010011906A1 (en) 2010-01-28
JP6095891B2 (ja) 2017-03-15
AU2009273889B2 (en) 2013-01-31
JP6375353B2 (ja) 2018-08-15

Similar Documents

Publication Publication Date Title
HRP20150093T1 (hr) Tjedna administracija 25-hidroksi vitamina d3 za održavanje povišene koncentracije u krvi pri stacionarnoj farmakokinetici
HK1212210A1 (en) Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3
PL2334295T3 (pl) Kompozycja farmaceutyczna zawierająca kwas eikozapentaenowy i kwas nikotynowy oraz sposoby jej zastosowania
EP2188259A4 (en) PROCESS FOR THE PREPARATION AND ADMINISTRATION OF CHINOLINE DERIVATIVES AS ANTICROBIAL AGENTS
EP2346430A4 (en) ECCENTRIC BALLOON LASER CATHETER
PT2519230T (pt) Modulação de solubilidade, estabilidade, absorção, metabolismo e perfil farmacocinético de fármacos lipofílicos por esteróis
EP2271347A4 (en) ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
IL206835A0 (en) Methods and compositions for oral administration of insulin
EP2214715A4 (en) METHOD OF ADMINISTERING AN ANTI-CANCER AGENT TO A CELL
AP2627A (en) New form of administration of racecadotril
IL207589A (en) A combination of Vitamin D and 25-Hydroxyvitamin 3D
SI3005986T1 (sl) Infuzija zdravil
HK1154200A1 (en) Vitamin compositions and method of administration to a human being
IL207049A0 (en) Synthesis of resorcylic acid lactones useful as therapeutic agents
WO2010132347A9 (en) Docosahexaenoic acid for the treatment of heart failure
EP2431038A4 (en) PHARMACEUTICAL COMPOSITION WITH ARBIDOL IN THE FORM OF PHOSPHOLIPID NANOPARTICLES
SG2013089776A (en) Combined drug administration
HK1152247A1 (en) Methods of treatment employing prolonged continuous infusion of belinostat belinostat
EP2276478A4 (en) METHOD FOR THE ADMINISTRATION OF PROSTRATIN AND STRUCTURAL ANALOGUE THEREOF
EP2548566A4 (en) COMPOSITION FOR TRANSNASAL ADMINISTRATION AND METHOD OF PRODUCING THE SAME
TWM389539U (en) Outward-expanding handrail structure of wheelchair
PL389431A1 (pl) Kompozycja liposomowa zawierająca pochodne witaminy B3
HU0800679D0 (en) Technology for production of fire-fighting power
UA63226U (en) Pancreatonecrosis simulation method
PL117809U1 (pl) Dzielona stopa słupka uchylnego dwukierunkowo